Director, Setidegrasib Marketing (NSCLC Launch), US Oncology

Setidegrasib Launch Lead (NSCLC), US Oncology

About Astellas

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Learn more at Astellas.com.

Are you driven to make a real difference in the lives of patients?

We're seeking passionate individuals who thrive in dynamic environments, embrace new ideas, and aren't afraid to take intelligent risks. People who act with unwavering integrity and are deeply committed to making a tangible impact.

Purpose & Scope

The U.S. Setidegrasib Launch Lead, NSCLC is responsible for leading U.S. commercial launch strategy and execution readiness for setidegrasib (A3082) in non-small cell lung cancer, a key oncology pipeline asset. This role will partner closely with cross-functional teams and co-creation affiliates to shape insight-driven launch plans, stakeholder engagement strategies, and commercial priorities that support a competitive U.S. launch and maximize long-term brand value. Responsibilities may evolve beyond NSCLC based on brand and business needs.

Role and Responsibilities

• Develop and lead the U.S. commercial launch strategy and integrated launch plan for setidegrasib in NSCLC, including launch objectives, critical success factors, key milestones, governance, and cross-functional execution roadmap.
• Translate patient, customer, scientific, biomarker/testing, pathway, market access, and competitive insights into clear brand priorities, business recommendations, and launch execution choices.
• Shape U.S. brand positioning, messaging, and core launch materials in partnership with medical, legal, regulatory, market access, sales, training, agency, and global/co